Hm Payson & CO Gilead Sciences, Inc. Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Hm Payson & CO holds 5,549 shares of GILD stock, worth $500,464. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,549

Previous 7,226 23.21%

Holding current value

$500,464

Previous $495,000 6.06%

% of portfolio

0.01%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$66.59 - $83.99 $111,671 - $140,851	-1,677 Reduced 23.21%	5,549 $465,000
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $57,782 - $66,685	915 Added 14.5%	7,226 $495,000
Q1 2024 Jun 20, 2024	SELL	$71.58 - $87.29 $7,229 - $8,816	-101 Reduced 1.58%	6,311 $462,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $56,344 - $63,896	-769 Reduced 10.71%	6,412 $519,000
Q3 2023 Nov 06, 2023	BUY	$73.94 - $80.67 $14,788 - $16,134	200 Added 2.86%	7,181 $538,000
Q1 2023 Apr 18, 2023	BUY	$77.31 - $88.08 $38,655 - $44,040	500 Added 7.71%	6,981 $579,000
Q4 2022 Feb 06, 2023	SELL	$62.32 - $89.47 $58,580 - $84,101	-940 Reduced 12.67%	6,481 $556,000
Q3 2022 Oct 25, 2022	BUY	$59.54 - $68.01 $53,586 - $61,209	900 Added 13.8%	7,421 $458,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $18,816 - $21,193	-326 Reduced 4.76%	6,521 $403,000
Q1 2022 May 12, 2022	SELL	$57.92 - $72.58 $59,310 - $74,321	-1,024 Reduced 13.01%	6,847 $407,000
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $84,992 - $96,468	-1,310 Reduced 14.27%	7,871 $571,000
Q2 2021 Aug 17, 2021	SELL	$63.47 - $69.35 $2,221 - $2,427	-35 Reduced 0.38%	9,181 $632,000
Q1 2021 Jun 15, 2021	SELL	$60.0 - $68.46 $6,900 - $7,872	-115 Reduced 1.23%	9,216 $596,000
Q4 2020 Mar 10, 2021	SELL	$56.65 - $64.55 $25,719 - $29,305	-454 Reduced 4.64%	9,331 $544,000
Q3 2020 Dec 21, 2020	BUY	$62.1 - $78.08 $28,193 - $35,448	454 Added 4.87%	9,785 $618,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $25,319 - $29,400	-350 Reduced 3.62%	9,331 $718,000
Q1 2020 Jul 01, 2020	SELL	$62.63 - $80.22 $90,813 - $116,319	-1,450 Reduced 13.03%	9,681 $724,000
Q4 2019 Feb 18, 2020	SELL	$61.62 - $67.78 $11,338 - $12,471	-184 Reduced 1.63%	11,131 $723,000
Q3 2019 Nov 12, 2019	SELL	$62.51 - $69.0 $231,537 - $255,576	-3,704 Reduced 24.66%	11,315 $717,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $1.12 Million - $1.25 Million	-18,046 Reduced 54.58%	15,019 $1.02 Million
Q1 2019 Jul 31, 2019	BUY	$62.53 - $70.05 $1.91 Million - $2.14 Million	30,525 Added 1201.77%	33,065 $2.15 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $4.4 Million - $5.75 Million	-72,732 Reduced 96.63%	2,540 $159,000
Q3 2018 Nov 30, 2018	SELL	$71.28 - $78.92 $3.34 Million - $3.69 Million	-46,792 Reduced 38.33%	75,272 $5.81 Million
Q2 2018 Aug 27, 2018	SELL	$64.88 - $75.68 $1 Million - $1.17 Million	-15,430 Reduced 11.22%	122,064 $8.65 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $1.72 Million - $2.1 Million	23,662 Added 20.79%	137,494 $10.4 Million
Q4 2017 Feb 16, 2018	SELL	$71.15 - $83.52 $126,362 - $148,331	-1,776 Reduced 1.54%	113,832 $8.16 Million
Q3 2017 Nov 06, 2017	BUY	$72.11 - $85.47 $8.34 Million - $9.88 Million	115,608	115,608 $9.37 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account